Market

iRhythm Growth Tested by Significant 2026 Cybersecurity Breach
Management & Regulatory iRhythm Growth Tested by Significant 2026 Cybersecurity Breach

A gross margin expansion to 72.8% in the second quarter of 2026 demonstrated iRhythm's operational scaling just as a significant cybersecurity crisis unfolded. The intersection of these two events creates a paradox for the digital healthcare giant, which has seen its Zio platform achieve

Can Bioengineering Create a Sustainable Medical Future?
Management & Regulatory Can Bioengineering Create a Sustainable Medical Future?

The traditional 'take-make-waste' model of medical manufacturing is being challenged by researchers who view the environmental footprint of healthcare as a critical engineering problem. For decades, the medical industry has operated under a strict mandate of patient safety and clinical sterility, a

Is Italy the Undisputed Leader of European Pharmaceutical CDMOs?
Management & Regulatory Is Italy the Undisputed Leader of European Pharmaceutical CDMOs?

The Italian CDMO sector has seen its export turnover quadruple over the last ten years, signaling a profound shift in the continent’s industrial power balance. This evolution has transformed Italy into the central pillar of the European pharmaceutical landscape, particularly through the excellence

Is the BPC-157 Wolverine Peptide Safe and Effective?
Research & Development Is the BPC-157 Wolverine Peptide Safe and Effective?

Doctors emphasize the importance of patient transparency regarding peptide use to prevent potential drug interactions and to monitor for any adverse physiological reactions. This chemical sequence, known formally as Body Protection Compound 157, has transcended its origins in laboratory research to

Grindr to Acquire PurposeMed for $250 Million to Launch Grindr Health
Management & Regulatory Grindr to Acquire PurposeMed for $250 Million to Launch Grindr Health

By combining the sexual wellness line Woodwork with Freddie’s clinical capabilities, Grindr is building an end-to-end medical infrastructure for its members. This move represents a profound shift from a platform once characterized primarily by social interaction into a comprehensive healthcare

How Can Z Codes Fix the Genetic Testing Reimbursement Crisis?
Tech & Innovation How Can Z Codes Fix the Genetic Testing Reimbursement Crisis?

The shift toward a genetic test management system is essential to ensure that the promise of personalized medicine is not undermined by systemic financial exploitation. Dr. Bill Kerr, the co-founder and chief executive officer of Avalon Healthcare Solutions, has identified a profound lack of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later